SunTrust analyst Kaila Krum initiates coverage on BioTelemetry (NASDAQ: BEAT) with a Buy rating and a price target of $58.00.The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE